Procter & Gamble Health Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Procter & Gamble Health Quarterly Results    (EMER)

Here are the latest quarterly results of Procter & Gamble Health. For more details, see the Procter & Gamble Health financial fact sheet and Procter & Gamble Health share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Procter & Gamble Health Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
3
Sep-20
3
Dec-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,3102,3362,2522,3682,2816,34510,09510,184 
Other income Rs m1771756761103969694 
Turnover Rs m2,4872,5112,3192,4282,3846,44110,19010,278 
Expenses Rs m1,8091,7911,7531,8771,6945,2426,7126,760 
Gross profit Rs m5015454994905871,1033,3833,424 
Depreciation Rs m4345404342132118120 
Interest Rs m0000010421 
Profit before tax Rs m6356755265086481,0563,3573,377 
Tax Rs m228234168126183364818871 
Profit after tax Rs m4074413583824656922,5392,506 
Gross profit margin %21.723.322.220.725.817.433.533.6 
Effective tax rate %35.934.732.024.828.334.524.425.8 
Net profit margin %17.618.915.916.120.410.925.124.6 
Diluted EPS Rs 24.5 26.6 21.5 23.0 28.0 41.7 152.9 151.0  
Diluted EPS (TTM) Rs 77.2 84.0 80.7 95.6 99.1 114.2 245.6 373.6  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Procter & Gamble Health 1QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON   NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare PROCTER & GAMBLE HEALTH With:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON   NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

CIPLA at All Time High; BSE HEALTHCARE Index Up 1.1% (Market Updates)

Apr 20, 2021 | Updated on Apr 20, 2021

CIPLA share price has hit an all time high at Rs 966 (up 0.6%). The BSE HEALTHCARE Index is up by 1.1%. Among the top gainers in the BSE HEALTHCARE Index today are CIPLA (up 0.6%) and ABBOTT INDIA (up 1.1%). The top losers include PROCTER & GAMBLE HEALTH (down 0.3%) and BIOCON (down 0.3%).

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Apr 20, 2021 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - TEVA PHARMA COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS